AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

OSELTAMIVIR

15 registrations across 4 African markets— 8 active

Markets with OSELTAMIVIR

Recent registrations

Brand / ProductMarketHolderStatusExpires
ADYFLU
Gélule / 30 mg
🇹🇳TunisiaADWYAexpiredJan 2010
ADYFLU
Gélule / 45 mg
🇹🇳TunisiaADWYAexpiredJan 2010
SAIFLU 30
Gélule / 30 mg
🇹🇳TunisiaSAIPHexpiredDec 2009
SAIFLU 45
Gélule / 45 mg
🇹🇳TunisiaSAIPHexpiredDec 2009
TAMIFLU
Gélule / 75 mg
🇹🇳TunisiaROCHE PHARMA (SCHWEIZ) LTD SUISSEexpiredOct 2009
ADYFLU
Gélule / 75 mg
🇹🇳TunisiaADWYAexpiredOct 2009
SAIFLU 75
Gélule / 75 mg
🇹🇳TunisiaSAIPHexpiredAug 2009
Seltavir 30
Hard Gelatin Capsules
🇹🇿TanzaniaMSN Laboratories Private Limitedactive
TAMIFLU
gélule / 30 mg
🇸🇳SenegalF.HOFFMAN-LA ROCHE LTDactive
Seltavir 45
Capsules
🇹🇿TanzaniaMSN Laboratories Private Limitedactive
TAMIFLU
GELULE
🇲🇦Moroccoactive
GENFLU
GELULE
🇲🇦Moroccoactive
GENFLU
GELULE
🇲🇦Moroccoactive
TAMIFLU
gélule / 40 mg
🇸🇳SenegalF.HOFFMAN-LA ROCHE LTDactive
TAMIFLU
GELULE
🇲🇦Moroccoactive

OSELTAMIVIR in Africa — Regulatory Overview

OSELTAMIVIR is registered across 4 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Senegal, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 8 (53%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.